Pentasa is a medication used to treat inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Its active ingredient is mesalazine (also called 5-ASA), which helps to reduce inflammation in the intestines. Pentasa is typically used to treat both active disease and to maintain remission. Side Effects : Common: Nausea, headache, abdominal pain, diarrhea. Rare but serious: Kidney problems, blood disorders, severe allergic reactions. Precautions: Kidney Function: Monitor kidney function during treatment, especially for patients with pre-existing kidney conditions. Allergy: Not recommended for patients with known hypersensitivity to mesalazine or other ingredients in the formulation. Pregnancy & Lactation: Consult a healthcare provider before using Pentasa during pregnancy or breastfeeding. Interactions: May interact with other medications, including anticoagulants and immunosuppressants, so it is important to inform your doctor about all other medications being taken.

Treatment of Ulcerative Colitis (a type of IBD). Management of Crohn’s Disease. Prevention of flare-ups and to help maintain remission in patients with these conditions. Benefits: Reduces Inflammation: Helps control inflammation in the gastrointestinal tract, reducing symptoms like pain, diarrhea, and bleeding. Promotes Healing: Aids in the healing of the lining of the intestines affected by IBD. Long-term Use: Can be used long-term to maintain remission in people with Crohn's disease or ulcerative colitis.

Adults: The usual starting dose for treating ulcerative colitis or Crohn's disease is 1-2 tablets (500mg each) taken 3-4 times daily. The dose may be adjusted based on response or the severity of the condition. Maintenance Dose: Once the disease is under control, a lower dose may be recommended for maintenance treatment. Consultation: Always follow the doctor's prescription for accurate dosing.